Amid record highs in US indexes and broad-based gains, small-cap indexes outperformed large-caps, led by positive sentiment from strong labor market indicators and housing sales reports. In this environment of optimism and the possible reduction of the interest rate by the Federal Reserve, the analysis of tech-growth technologies can be interesting as they often show the ability to perform and the strength that goes well with the current market dynamics.
Name
Income Growth
Gain Growth
Growth Rating
Waystream Holding
22.16%
113.25%
★★★★★★★
Ascelia Pharma
76.15%
47.16%
★★★★★★★
Sarepta Therapeutics
24.00%
42.49%
★★★★★★★
Pharma Mar
25.97%
56.89%
★★★★★★★
CD Project
21.17%
29.59%
★★★★★★★
History of TG Therapeutics
34.66%
56.98%
★★★★★★★
Elliptic Laboratories
65.73%
103.55%
★★★★★★★
Vadivelu Comedy Alkami Technology
21.89%
98.60%
★★★★★★★
Alnylam Pharmaceuticals
22.35%
70.33%
★★★★★★★
Travere Therapeutics
31.70%
72.51%
★★★★★★★
Click here to see the full list of 1283 stocks from our High Growth Tech and AI Stocks screener.
Here’s a look at a few of the options from the screener.
Simply Wall St Growth Rating: ★★★★★☆
In a nutshell Beijing Vastdata Technology Co., Ltd provides data technology services in China and has a market capitalization of CN¥4.78 billion.
Operations: Vastdata Technology focuses on software and information technology services, generating CN¥365.24 million in revenue from this division.
Despite the current lack of profitability, Beijing Vastdata Technology is on the way to see significant changes. With an estimated revenue growth of an impressive 41.8% per year, surpassing the Chinese market average of 13.8%, the company is positioning itself as a potentially strong player in tech. This growth comes with an estimated revenue increase of 119.7% per annum, indicating strong growth once profitability has been achieved over the next three years. The latest earnings show reduced losses and increased sales, with revenue hitting CNY 266.87 million for the nine months ending September 2024 – a significant rise from CNY 163.46 million in the previous year – underscoring effective strategies to reverse the initial decline despite ongoing challenges such as discounting and declining share prices.
SHSE:603138 Earnings and Revenue Growth as on Nov 2024
Simply Wall St Growth Rating: ★★★★☆☆
In a nutshell Beijing Zhong Ke San Huan High-Tech Co., Ltd. operates in a high quality industry with a market value of CN¥12.66 billion.
Operations: Beijing Zhong Ke San Huan High-Tech Co., Ltd. focuses on high-tech industrial operations, leveraging its expertise to monetize through high-tech solutions. The company’s business model emphasizes innovation and development within its sector, contributing to its significant market presence.
Beijing Zhong Ke San Huan High-Tech has shown a remarkable commitment to innovation, with R&D costs reaching CNY 500 million, accounting for a significant 10% of its total revenue. This investment is in line with its plan to develop technological innovation in the midst of difficult market conditions, reflected by a revenue growth of 16.4% per year—higher than the average of the Chinese market. Despite the current obstacles leading to this year’s losses, the company’s aggressiveness in R&D and the earnings forecast of 82.8% per year indicate the possibility of recovery and future profitability. The company has also been determined to return value to shareholders by repurchasing shares worth CNY 107.95 million this year, reinforcing confidence in its direction despite financial instability.
SZSE: 000970 Revenue and Expenses Breakdown as of Nov 2024
Simply Wall St Growth Rating: ★★★★☆☆
In a nutshell Doushen (Beijing) Education & Technology INC. is a company involved in the education and technology sectors with a market capitalization of CN¥19.96 billion.
Operations: Doushen focuses on the Information Technology Services sector, generating CN¥910.10 million in revenue. The company’s operations are focused on developing technology within the education sector.
Doushen (Beijing) Education & Technology made a remarkable entry this year, turning a previous loss into a CNY 110.87 million profit, showing strong management and hard work. This change is confirmed by a recurring revenue rate of 38.4% per year, placing the company well above the industry average growth rate of 13.8%. Also, with R&D funds wisely allocated to the development of technology – evident from their recent shareholder meeting discussing the development of technology – their commitment to maintaining a competitive advantage in educational technology is clear. This effort is supported by an earnings forecast that predicts an annual growth of 23.8%, indicating the possibility of continued trends in market presence and financial health.
SZSE:300010 Earnings and Income Growth as of Nov 2024
Discover 1283 hidden gems among our High Growth Tech and AI Stocks screener with one click here.
Already have these companies? Connect your portfolio to Simply Wall St and get alerts on any new warning signs for your stocks.
Take control of your financial future with Simply Wall St, providing free, in-depth global market information to every investor.
This Simply Wall St article is casual in nature. We provide commentary based on historical data and analysts’ estimates only using an unbiased approach and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and it does not take into account your goals, or your financial situation. We aim to bring you long-term focused research driven by valuable data. Note that our analysis may not result in price-sensitive or quality-sensitive company advertisements. Simply Wall St has no position in any of the stocks mentioned.
The companies discussed in this article include SHSE:603138 SZSE:000970 and SZSE:300010.
Have a comment on this article? Worried about content? Contact us directly. Alternatively, email editorial-team@simplywallst.com
